| 期 |
标题 |
文件 |
| 卷 93, 编号 8 (2021) |
Obesity as a risk factor for diseases of the digestive system |
(Rus)
|
|
Andreev D., Kucheryavyy Y.
|
| 卷 93, 编号 8 (2021) |
Liver cirrosis and complication risk management |
(Rus)
|
|
Bakulin I., Oganezova I., Skalinskaya M., Skazyvaeva E.
|
| 卷 93, 编号 8 (2021) |
The role of visceral hypersensitivity in the pathogenesis of irritable bowel syndrome |
(Rus)
|
|
Makarova A., Ruchkina I., Parfenov A., Indeykina L., Romashkina N.
|
| 卷 93, 编号 8 (2021) |
Is histological remission of ulcerative colitis achievable? |
(Rus)
|
|
Knyazev O., Kagramanova A., Khomeriki S., Parfenov A.
|
| 卷 93, 编号 8 (2021) |
Rational treatment of patients with functional dyspepsia |
(Rus)
|
|
Kazakov A., Zyryanov S., Ushkalova E., Nasretdinova E.
|
| 卷 93, 编号 8 (2021) |
Combine therapy as a modern approach to treatment of allergic rhinitis |
(Rus)
|
|
Emelyanov A.
|
| 卷 93, 编号 8 (2021) |
Roles of active forms of vitamin D in supporting innate immune systems and in reducing excess inflammation in COVID-19 |
(Rus)
|
|
Gromova O., Torshin I., Chuchalin A., Kozhevnikova E., Malyavskaya S.
|
| 卷 93, 编号 7 (2021) |
Treatment of thrombotic thrombocytopenic purpura |
(Rus)
|
|
Galstyan G., Maschan A., Klebanova E., Kalinina I.
|
| 卷 93, 编号 6 (2021) |
Role of the intestinal MALT in pathogenesis of the IgA-nephropathy |
(Rus)
|
|
Guliaev S., Strizhakov L., Chebotareva N., Moiseev S.
|
| 卷 93, 编号 6 (2021) |
The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease |
(Rus)
|
|
Mikhailova N.
|
| 卷 93, 编号 6 (2021) |
Treatment of thrombotic thrombocytopenic purpura |
(Rus)
|
|
Galstyan G., Maschan A., Klebanova E., Kalinina I.
|
| 卷 93, 编号 5 (2021) |
Locomotive syndrome: from paradigms to clinical reality |
(Rus)
|
|
Putilina M., Teplova N., Lila A., Zagorodniy N.
|
| 卷 93, 编号 5 (2021) |
Modern approaches to immunization of patients of rheumatologic profile |
(Rus)
|
|
Belov B., Tarasova G., Muravyeva N.
|
| 卷 93, 编号 5 (2021) |
Advantages of the use of metformin in patients with impaired uric acid metabolism |
(Rus)
|
|
Eliseev M., Panevin T., Zhelyabina O., Nasonov E.
|
| 卷 93, 编号 5 (2021) |
The role of the angiotensins in the pathogenesis of inflammatory joint disease |
(Rus)
|
|
Gordeev A., Galushko E., Savushkina N.
|
| 卷 93, 编号 4 (2021) |
AL-amyloidosis with cardiac involvement. Diagnostic capabilities of non-invasive methods |
(Rus)
|
|
Gudkova A., Lapekin S., Bezhanishvili T., Trukshina M., Davydova V., Krutikov A., Kulikov A., Streltsova A., Andreeva S., Grozov R., Poliakova A., Kostareva A., Salogub G., Shlyakhto E.
|
| 卷 93, 编号 4 (2021) |
The role of cardiac magnetic resonance imaging (cardiovascular magnetic resonance) in defining the prognosis of patients with acute ST-segment elevation myocardial infarction. Part 1. Indications and contraindications to cardiovascular magnetic resonance |
(Rus)
|
|
Terenicheva M., Stukalova O., Shakhnovich R., Ternovoy S.
|
| 卷 93, 编号 4 (2021) |
Central hemodynamic monitoring in patients with cardiogenic shock |
(Rus)
|
|
Syrkina A., Ryabov V.
|
| 卷 93, 编号 4 (2021) |
Exocrine pancreas insufficiency: clinical significance and approaches to correction from evidence medicine |
(Rus)
|
|
Maev I., Kucheryavyy Y., Andreev D.
|
| 卷 93, 编号 4 (2021) |
Mixed steatohepatitis: more questions than answers (part 2) |
(Rus)
|
|
Raikhelson K., Kondrashina E., Pazenko E.
|
| 卷 93, 编号 4 (2021) |
Extraesophageal signs of gastroesophageal reflux disease: otorhinolaryngologist’s view |
(Rus)
|
|
Radtsig E., Konstantinov D.
|
| 卷 93, 编号 3 (2021) |
"Difficult" pneumonia |
(Rus)
|
|
Zaicev A., Sinopalnikov A.
|
| 卷 93, 编号 3 (2021) |
Pulmonary embolism and diffuse alveolar bleeding: combination options and therapy features |
(Rus)
|
|
Tret’yakov A., Radenska-Lopovok S., Novikov P., Tret’yakova V., Zakharchenko S.
|
| 卷 93, 编号 3 (2021) |
Differential diagnosis of chylothorax in therapeutic practice |
(Rus)
|
|
Makarova M., Baimakanova G., Krasovsky S.
|
| 卷 93, 编号 3 (2021) |
The pathophysiological role of adipokines in the development of bronchial asthma combined with obesity |
(Rus)
|
|
Kytikova O., Antonyuk M., Gvozdenko T., Novgorodtseva T.
|
| 卷 93, 编号 3 (2021) |
Idiopathic interstitial pneumonias |
(Rus)
|
|
Ilkovich M., Novikova L.
|
| 卷 93, 编号 3 (2021) |
Modern understanding of bronchial asthma with fixed airflow obstruction |
(Rus)
|
|
Kraposhina A., Sobko E., Demko I., Kacer A., Kazmerchuk O., Abramov Y.
|
| 卷 93, 编号 3 (2021) |
COVID-19 and the small intestine |
(Rus)
|
|
Bakharev S., Baulo E., Bykova S., Dbar S., Parfenov A.
|
| 卷 93, 编号 2 (2021) |
Molecular factors associated with regression of liver fibrosis of alcoholic etiology |
(Rus)
|
|
Kiseleva Y., Zharikov Y., Maslennikov R., Pavlov C., Nikolenko V.
|
| 卷 93, 编号 2 (2021) |
Features of intestinal microbiota disorders in the development of metabolic disorders in non-alcoholic fatty liver disease |
(Rus)
|
|
Livzan M., Krolevets T., Mozgovoy S., Nikolaev N., Nelidova A.
|
| 卷 93, 编号 2 (2021) |
Clinical value of antibodies in inflammatory bowel diseases |
(Rus)
|
|
Aleksandrova E., Novikov A., Lukina G., Parfenov A.
|
| 卷 93, 编号 2 (2021) |
Pathogenetic aspects of the development of cholelithiasis in patients with metabolic syndrome |
(Rus)
|
|
Uspenskiy Y., Fominykh Y., Nadzhafova K., Vovk A., Koshcheev A.
|
| 卷 93, 编号 2 (2021) |
Fecal microbiota transplantation: donor selection criteria, storage and preparation of biomaterials (review of current recommendations) |
(Rus)
|
|
Iakupova A., Abdulkhakov S., Safin A., Alieva I., Oslopova J., Abdulkhakov R.
|
| 卷 93, 编号 2 (2021) |
New approaches to the pathogenesis, clinic, and treatment of hepatic encephalopathy |
(Rus)
|
|
Podymova S.
|
| 卷 93, 编号 1 (2021) |
Gallbladder polyps: modern approaches to diagnostics and treatment |
(Rus)
|
|
Onuchina E.
|
| 卷 93, 编号 1 (2021) |
BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic |
(Rus)
|
|
Kalyuzhin O., Andronova T., Karaulov A.
|
| 卷 93, 编号 1 (2021) |
Pharmacotherapy for acute respiratory infections caused by influenza viruses: current possibilities |
(Rus)
|
|
Zyryanov S., Butranova O., Gaidai D., Kryshen K.
|
| 卷 93, 编号 1 (2021) |
Inflammatory diseases of the pancreas: what new do we know about the mechanisms of their development in the 21st century? |
(Rus)
|
|
Akhmedov V., Gaus O.
|
| 卷 93, 编号 1 (2021) |
The asymptomatic microhematuria in the physician’s practice |
(Rus)
|
|
Drapkina O., Samorodskaya I., Larina V.
|
| 卷 93, 编号 1 (2021) |
Current understanding of the role of age-related hypogonadism in the development of cardiovascular diseases |
(Rus)
|
|
Lebedeva N., Hoffman V.
|
| 卷 93, 编号 1 (2021) |
Calcification and atherosclerosis of the coronary arteries |
(Rus)
|
|
Kashtanova E., Polonskaya Y., Ragino Y.
|
| 卷 93, 编号 1 (2021) |
Cardio-ankle vascular index (CAVI) in diagnostics, risk and severity evaluation of magistral vessels lesion in patients with cardio-vascular diseases and type 2 diabetes |
(Rus)
|
|
Verner V., Mel’nik M., Knjazeva S.
|
| 卷 93, 编号 1 (2021) |
Characteristics of arterial hypertension clinical course in patients with obesity and anxiety-depressive disorders |
(Rus)
|
|
Vasyuk Y., Dovzhenko T., Dubrovskaya T., Nesterova E., Shupenina E.
|
| 卷 92, 编号 11 (2020) |
Opportunities for use the cascade model of medical care for people living with HIV |
(Rus)
|
|
Pokrovskaya A., Pokrovskiy V., Akimkin V.
|
| 卷 92, 编号 11 (2020) |
Epidemiological and clinical aspects of diagnosis, treatment and prophylaxis of imported malaria cases in Russian Federation |
(Rus)
|
|
Tokmalaev A., Baranova A., Maleev V.
|
| 卷 92, 编号 11 (2020) |
Risks of oncologic pathology in parasitosis at the present time |
(Rus)
|
|
Omarova K., Aleshina N., Ponezhevа Z., Gorelov A., Maleev V., Akimkin V.
|
| 卷 92, 编号 11 (2020) |
Current view on Blastocystis species: clinical forms, diagnosis and treatment |
(Rus)
|
|
Maleev V., Tokmalaev A., Kozhevnikova G., Tsvetkova N., Polovinkina N., Golub V., Maksimova M., Barysheva I., Konnov V., Kharlamova T.
|
| 卷 92, 编号 11 (2020) |
Umifenovir and coronavirus infections: a review of research results and clinical practice |
(Rus)
|
|
Leneva I., Pshenichnaya N., Bulgakova V.
|
| 卷 92, 编号 11 (2020) |
The role of vitamin D in seasonal acute respiratory viral infections and COVID-19 |
(Rus)
|
|
Pigarova E., Povalyaeva A., Dzeranova L., Rozhinskaya L., Mokrysheva N.
|
| 卷 92, 编号 11 (2020) |
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria |
(Rus)
|
|
Sturov N., Popov S., Mamporia N., Mager A.
|
| 卷 92, 编号 11 (2020) |
The problem of global development of antibiotic resistant nosocomial pathogens |
(Rus)
|
|
Gabrielyan N., Sharapchenko S., Kisil О., Kormilitsina V., Drabkina I., Safonova Т., Petrukhina М., Saitgareev R., Zakharevich V.
|
| 卷 92, 编号 10 (2020) |
The prevalence of autoimmune endocrine diseases in vitiligo patients |
(Rus)
|
|
Troshina E., Volnukhin V., Petrov V., Nuralieva N., Yukina M., Orlova E., Frigo N.
|
| 卷 92, 编号 10 (2020) |
Gut microbiota is a factor of risk for obesity and type 2 diabetes |
(Rus)
|
|
Demidova T., Lobanova K., Oinotkinova O.
|
| 卷 92, 编号 9 (2020) |
Choosing of therapy for a patient with dorsalgia |
(Rus)
|
|
Kamchatnov P., Abusueva B., Khanmurzaeva S., Khanmurzaeva N.
|
| 卷 92, 编号 9 (2020) |
Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention |
(Rus)
|
|
Oynotkinova O., Nikonov E., Demidova T., Baranov A., Kryukov E., Dedov E., Karavashkina E.
|
| 卷 92, 编号 9 (2020) |
Diagnostic and prognostic significance of QRS-T angle |
(Rus)
|
|
Blinova E., Sakhnova T., Yurasova E.
|
| 卷 92, 编号 9 (2020) |
The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat |
(Rus)
|
|
Gratsianskaya S., Valieva Z., Martynyuk T.
|
| 卷 92, 编号 9 (2020) |
Role of magnetic resonance imaging in patients with aortic stenosis before and after replacement of the valve |
(Rus)
|
|
Shariya M., Ustyuzhanin D., Lepilin P., Imaev T., Komlev A., Belyaevskaya A., Ternovoy S.
|
| 卷 92, 编号 9 (2020) |
Hypertrophic cardiomyopathy in elderly: causes, diagnostic and treatment approaches |
(Rus)
|
|
Chumakova O.
|
| 卷 92, 编号 9 (2020) |
Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension |
(Rus)
|
|
Aleevskaya A., Vyborov O., Gramovich V., Martynyuk T.
|
| 卷 92, 编号 9 (2020) |
Decreasing cardiovascular morbidity: how to improve adherence to the treatment in the translational era |
(Rus)
|
|
Zhirov I.
|
| 卷 92, 编号 8 (2020) |
Diet therapy for irritable bowel syndrome |
(Rus)
|
|
Bakulin I., Avalueva E., Оrеshkо L., Sitkin S., Shevyakov M., Serkova M., Semenova E.
|
| 卷 92, 编号 8 (2020) |
Evaluation and management of infectious esophagitis in immunocompromised patients and immunocompetent individuals |
(Rus)
|
|
Trukhmanov A., Makushina A., Storonova O., Ivashkina N.
|
| 151 - 213 的 213 信息 |
<< < 1 2
|
